Hunan Key Laboratory of Typical Environmental Pollution and Health Hazards, School of Public Health, Hengyang Medical School, University of South China.
Department of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University.
J Nutr Sci Vitaminol (Tokyo). 2021;67(6):391-396. doi: 10.3177/jnsv.67.391.
Colorectal cancer is the main leading cause of death from cancer worldwide. Protective effects of vitamin B1 on colorectal cancer have been observed in some epidemiological studies. A systematic review and meta-analysis of observational studies evaluated the association of intake of vitamin B1 with the incidence of colorectal cancer. Relevant studies were identified in MEDLINE via PubMed (published up to September 2020). We extracted data from articles on vitamin B1 and used a multivariable-adjusted odds ratio (OR) and a random-effects model for analysis. We found seven articles meeting the inclusion criteria (1 of cohort studies and 6 case-control studies) and a total of 6,184 colorectal cancer cases were included in this meta-analysis. The multivariable-adjusted OR for pooled studies for the association of roughly the same high dose level versus the lowest vitamin B1 intake and the risk of colorectal cancer was 0.76 (95% confidence interval ([95%CI]: 0.65, 0.89). This meta-analysis studied the relationship between vitamin B1 and colorectal cancer. We found vitamin B1 intake was inversely associated with the risk of colorectal cancer. However, further research and large sample studies need to be conducted to better validate the result.
结直肠癌是全球癌症死亡的主要原因。一些流行病学研究观察到维生素 B1 对结直肠癌有保护作用。对观察性研究的系统评价和荟萃分析评估了维生素 B1 的摄入量与结直肠癌发病率之间的关系。通过 PubMed 在 MEDLINE 中确定了相关研究(截至 2020 年 9 月发表)。我们从关于维生素 B1 的文章中提取数据,并使用多变量调整的比值比(OR)和随机效应模型进行分析。我们发现符合纳入标准的 7 篇文章(1 项队列研究和 6 项病例对照研究),荟萃分析共纳入 6184 例结直肠癌病例。多变量调整的汇总研究 OR 表明,大致相同的高剂量水平与最低维生素 B1 摄入量相比,结直肠癌的风险为 0.76(95%置信区间 [95%CI]:0.65,0.89)。本荟萃分析研究了维生素 B1 与结直肠癌之间的关系。我们发现维生素 B1 的摄入量与结直肠癌的风险呈负相关。然而,需要进一步开展研究和大样本研究,以更好地验证这一结果。